①Niccolo de Masi, CEO of IonQ, stated that significant advancements in the field of quantum computing are on the horizon, with the potential to achieve ‘quantum supremacy’ in the coming quarters or even years; ②Previously, IonQ was involved in the development of a quantum-accelerated computational chemistry workflow, which could lead to breakthroughs in the medical and pharmaceutical sectors. Additionally, IonQ claims to be at the forefront in cracking RSA encryption algorithms.

Cailian, July 25 (Editor Zhao Hao) The CEO of the prominent U.S. quantum computing company $IonQ Inc (IONQ.US)$ Niccolo de Masi, recently stated that significant advancements in the field of quantum computing are rapidly approaching.

In a local interview on Thursday (July 24), de Masi said, “The era of so-called ‘quantum supremacy’ ($Quantum (QMCO.US)$ supremacy) is just around the corner.”

‘It may arrive in the next few quarters or even years, which is clearly exciting because it will enable us to drive advancements in various application sciences using quantum technology.’

IonQ is one of the major players in the quantum field in the United States, alongside other companies such as $Rigetti Computing (RGTI.US)$ 、 $D-Wave Quantum (QBTS.US)$ 、 $Quantum Computing (QUBT.US)$ DeMassi stated that IonQ is developing quantum computers and quantum networking equipment.

Quantum computing is a new paradigm of computation based on the principles of quantum mechanics, offering significantly greater parallel processing capabilities than classical computing. It has the potential to solve complex problems that are difficult for traditional computers to handle.

As $Alphabet-C (GOOG.US)$ 、 $Microsoft (MSFT.US)$ 、 $Amazon (AMZN.US)$ 、 $IBM Corp (IBM.US)$ Both the U.S. government and Wall Street are investing heavily in the research and development of quantum computers, with growing interest in the technology among financial institutions.

$NVIDIA (NVDA.US)$ Investors were particularly encouraged by the optimistic remarks of CEO Jensen Huang last month, who stated that quantum computing is ‘reaching a turning point’ and that practical applications are arriving faster than he had previously anticipated.

In the interview, DeMarco described the potential breakthroughs that quantum computing could bring to the medical and pharmaceutical fields, specifically mentioning a collaboration between IonQ, NVIDIA, Amazon AWS, and$AstraZeneca (AZN.US)$

Last month, IonQ announced a partnership with $AstraZeneca (AZN.US)$ The research project conducted in collaboration with AWS and NVIDIA has yielded results, demonstrating a quantum-accelerated computational chemistry workflow. This project is expected to drive innovation in healthcare, life sciences, and the chemical industry.

Demasi commented that viewing molecular structures from a quantum perspective could lead to significant advancements in drug discovery.

He also stated that IonQ is participating in the global quantum race and emphasized the company’s leading position in cracking RSA encryption algorithms, which is a widely used encryption technology.

Demasi noted that IonQ is almost single-handedly representing the Western world in the race to crack RSA. “Once this happens, the world will need our quantum network devices to ensure that the world and civilization as we know it can continue to function.”

编辑/rice